These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17659311)

  • 1. Efficacy and safety of dihydroartemisinin-piperaquine.
    Myint HY; Ashley EA; Day NP; Nosten F; White NJ
    Trans R Soc Trop Med Hyg; 2007 Sep; 101(9):858-66. PubMed ID: 17659311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
    Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
    J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
    Karema C; Fanello CI; van Overmeir C; van Geertruyden JP; van Doren W; Ngamije D; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1105-11. PubMed ID: 16766006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
    Ashley EA; McGready R; Hutagalung R; Phaiphun L; Slight T; Proux S; Thwai KL; Barends M; Looareesuwan S; White NJ; Nosten F
    Clin Infect Dis; 2005 Aug; 41(4):425-32. PubMed ID: 16028147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
    Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
    Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.
    Karunajeewa H; Lim C; Hung TY; Ilett KF; Denis MB; Socheat D; Davis TM
    Br J Clin Pharmacol; 2004 Jan; 57(1):93-9. PubMed ID: 14678346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
    Mayxay M; Thongpraseuth V; Khanthavong M; Lindegårdh N; Barends M; Keola S; Pongvongsa T; Phompida S; Phetsouvanh R; Stepniewska K; White NJ; Newton PN
    Trop Med Int Health; 2006 Aug; 11(8):1157-65. PubMed ID: 16903879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
    Giao PT; de Vries PJ; Hung le Q; Binh TQ; Nam NV; Kager PA
    Trop Med Int Health; 2004 Feb; 9(2):209-16. PubMed ID: 15040557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial.
    Ahmed R; Poespoprodjo JR; Syafruddin D; Khairallah C; Pace C; Lukito T; Maratina SS; Asih PBS; Santana-Morales MA; Adams ER; Unwin VT; Williams CT; Chen T; Smedley J; Wang D; Faragher B; Price RN; Ter Kuile FO
    Lancet Infect Dis; 2019 Sep; 19(9):973-987. PubMed ID: 31353217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria.
    Denis MB; Davis TM; Hewitt S; Incardona S; Nimol K; Fandeur T; Poravuth Y; Lim C; Socheat D
    Clin Infect Dis; 2002 Dec; 35(12):1469-76. PubMed ID: 12471565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria.
    Krudsood S; Tangpukdee N; Thanchatwet V; Wilairatana P; Srivilairit S; Pothipak N; Jianping S; Guoqiao L; Brittenham GM; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):971-8. PubMed ID: 18613536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
    Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
    Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR
    Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria.
    Falade C; Makanga M; Premji Z; Ortmann CE; Stockmeyer M; de Palacios PI
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):459-67. PubMed ID: 15837358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Response to Dihydroartemisinin-Piperaquine for
    Poespoprodjo JR; Kenangalem E; Wafom J; Chandrawati F; Puspitasari AM; Ley B; Trianty L; Korten Z; Surya A; Syafruddin D; Anstey NM; Marfurt J; Noviyanti R; Price RN
    Am J Trop Med Hyg; 2018 Mar; 98(3):677-682. PubMed ID: 29345221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
    Tangpukdee N; Krudsood S; Thanachartwet W; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Wilairatana P; Phongtananant S; Kano S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1085-91. PubMed ID: 16438129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choreoathetosis - an unusual adverse effect of dihydroartemisinin-piperaquine: a case report.
    Kadia BM; Morfaw C; Simo ACG
    J Med Case Rep; 2017 Dec; 11(1):360. PubMed ID: 29282155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.